Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.75B | 4.70B | 4.64B | 4.47B | 3.96B | 5.16B |
Gross Profit | 1.92B | 1.85B | 1.66B | 1.63B | 491.00M | 836.00M |
EBITDA | 436.00M | 392.00M | 307.00M | 273.00M | 281.00M | 548.00M |
Net Income | -8.00M | -31.00M | -76.00M | -14.00M | -47.00M | 198.00M |
Balance Sheet | ||||||
Total Assets | 4.81B | 5.00B | 4.77B | 5.05B | 4.57B | 5.41B |
Cash, Cash Equivalents and Short-Term Investments | 31.00M | 28.00M | 54.00M | 111.00M | 175.00M | 389.00M |
Total Debt | 2.13B | 2.12B | 1.94B | 2.07B | 1.52B | 2.06B |
Total Liabilities | 3.11B | 3.23B | 2.99B | 3.13B | 2.64B | 3.46B |
Stockholders Equity | 1.67B | 1.72B | 1.74B | 1.87B | 1.88B | 1.75B |
Cash Flow | ||||||
Free Cash Flow | 108.00M | 88.00M | 159.00M | -362.00M | -90.00M | 324.00M |
Operating Cash Flow | 271.00M | 272.00M | 510.00M | 144.00M | 211.00M | 587.00M |
Investing Cash Flow | -119.00M | -150.00M | -332.00M | -486.00M | -247.00M | -203.00M |
Financing Cash Flow | -147.00M | -149.00M | -225.00M | 272.00M | -529.00M | -156.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | C$14.23B | 18.63 | 15.20% | 1.46% | 7.90% | 19.55% | |
71 Outperform | C$2.56B | 13.42 | 10.79% | 7.66% | 4.69% | 4.54% | |
68 Neutral | C$1.68B | 9.38 | 9.65% | 9.45% | -2.58% | 100.21% | |
61 Neutral | $17.75B | 12.51 | -5.49% | 3.06% | 1.43% | -14.10% | |
60 Neutral | $1.00B | ― | -0.47% | 4.84% | 2.77% | 81.01% | |
58 Neutral | C$107.57M | ― | -12.57% | 4.42% | -3.54% | -244.21% | |
― | $10.28B | 18.36 | 14.88% | 1.49% | ― | ― |
Cascades Inc. reported its second-quarter financial results for 2025, highlighting a slight increase in sales to $1,187 million and an adjusted EBITDA of $137 million. Despite a net loss per share, the company saw improvements in operating income and a reduction in net debt. The packaging segment benefited from price increases and stable shipments, while the tissue segment maintained stable results despite higher operational costs. The company anticipates a slightly better performance in the third quarter, with stable packaging results and stronger tissue performance expected.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. has announced the permanent closure of its corrugated medium manufacturing facility in Niagara Falls, NY, as part of its strategy to optimize its packaging production platform. This decision, which will affect 123 employees, is aimed at enhancing profitability and customer service levels. Despite the closure, Cascades remains committed to strategic growth and will provide job search support to the affected employees. The company emphasizes that the closure will not impact its ability to serve customers due to its streamlined operations.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. announced the pricing of a private placement of US$400 million in Senior Notes due 2030, with a 6.750% interest rate. The proceeds will be used to redeem existing notes, repay part of its revolving credit facility, and cover transaction costs, potentially strengthening its financial position and operational flexibility.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. announced a proposed private offering of US$400 million in Senior Notes due 2030, with the intention to use the proceeds to redeem existing notes, repay part of its revolving credit facility, and cover transaction expenses. This move is aimed at optimizing the company’s financial structure and could enhance its market position by reducing debt and improving liquidity.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.